Evaluations of the clinical pathway in children with Mycoplasma pneumoniae pneumonia
10.3969/j.issn.1000-3606.2014.06.007
- VernacularTitle:儿童肺炎支原体肺炎临床路径实施效果评价
- Author:
Lili ZHU
;
Hailin ZHANG
;
Shunhang WEN
;
Yan ZHANG
;
Changchong LI
- Publication Type:Journal Article
- Keywords:
Mycoplasma pneumoniae pneumonia;
clinical pathway;
variations;
child
- From:
Journal of Clinical Pediatrics
2014;(6):528-531
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy of the clinical pathway introduced in children with Mycoplasma pneu-moniae pneumonia (MMP). Methods Based on a retrospective study, the length of hospital stay, hospital expenses and curative rate were compared between 145 MMP patients managed according to clinical pathway and other 45 MMP patients. The causes of variation were analyzed in the clinical pathway group as well. Results The length of hospital stay in clinical pathway group [9 (6~10) days] was significantly shorter than that in the control group [10 (7-12.5) days] (P=0.003). The curative rate (93.8%) was significantly higher than that in the control group (84.4%) (P=0.043). The hospital expenses [4 696.5 (3 608.3-5 677.6) CNY] was significantly higher than that in the control group [3175.3 (2490.8-4585.0) CNY] (P<0.001). The variation rate of clinical pathway was 48.3%(70/145 cases) in clinical pathway group. Conclusions The curative rate is improved and the length of hospital stay is shortened after the clinical pathway is introduced in MMP children. However, there is a high variation rate in the clinical pathway. It is necessary to optimize the clinical pathway before it is adapted in clinic.
